Search Results

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

The resource is intended for primary care providers who care for individuals and populations who may be at risk for infection with M. tuberculosis. The guide includes latent TB infection diagnosis and treatment information, sample documentation forms, and additional resources.

The purpose of this manual is to provide the clinician with updated recommendations for managing the drug-drug interactions that occur when using antiretroviral therapy during tuberculosis treatment.

This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the Northeastern National Tuberculosis Center. This booklet provides information on treatment for TB infection, treatment for TB disease, and how to stay...

This technical information note provides guidance to TB programme managers and quantification and procurement officers. The note includes information about the child-friendly DR-TB formulations and guidance on how to quantify and plan an order.

This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the New Jersey Medical School Global Tuberculosis Institute. All of these patient education materials can be found on the following webpage: www.cdc.gov/tb...

The materials were developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The materials include a patient education brochure, medication tracker, and symptom checklist. The brochure contains information on latent TB infection, the...

This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.

This is a flipbook from the Multnomah Health Department for patients with tuberculosis (TB) disease. The flipbook has information on TB disease, testing, case management, treatment, and more.